You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

CLINICAL TRIALS PROFILE FOR NEXTERONE

✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for nexterone

Subscribe to access the full database, or Subscribe
Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT01401647 ↗	Amiodarone, Lidocaine or Neither for Out-Of-Hospital Cardiac Arrest Due to Ventricular Fibrillation or Tachycardia	Completed	American Heart Association	Phase 3	2012-05-01	The primary objective of the trial is to determine if survival to hospital discharge is improved with early therapeutic administration of a new Captisol-Enabled formulation of IV amiodarone (Nexterone-PM101) compared to placebo.
NCT01401647 ↗	Amiodarone, Lidocaine or Neither for Out-Of-Hospital Cardiac Arrest Due to Ventricular Fibrillation or Tachycardia	Completed	Canadian Institutes of Health Research (CIHR)	Phase 3	2012-05-01	The primary objective of the trial is to determine if survival to hospital discharge is improved with early therapeutic administration of a new Captisol-Enabled formulation of IV amiodarone (Nexterone-PM101) compared to placebo.
NCT01401647 ↗	Amiodarone, Lidocaine or Neither for Out-Of-Hospital Cardiac Arrest Due to Ventricular Fibrillation or Tachycardia	Completed	Defence Research and Development Canada	Phase 3	2012-05-01	The primary objective of the trial is to determine if survival to hospital discharge is improved with early therapeutic administration of a new Captisol-Enabled formulation of IV amiodarone (Nexterone-PM101) compared to placebo.
NCT01401647 ↗	Amiodarone, Lidocaine or Neither for Out-Of-Hospital Cardiac Arrest Due to Ventricular Fibrillation or Tachycardia	Completed	Heart and Stroke Foundation of Canada	Phase 3	2012-05-01	The primary objective of the trial is to determine if survival to hospital discharge is improved with early therapeutic administration of a new Captisol-Enabled formulation of IV amiodarone (Nexterone-PM101) compared to placebo.
NCT01401647 ↗	Amiodarone, Lidocaine or Neither for Out-Of-Hospital Cardiac Arrest Due to Ventricular Fibrillation or Tachycardia	Completed	National Heart, Lung, and Blood Institute (NHLBI)	Phase 3	2012-05-01	The primary objective of the trial is to determine if survival to hospital discharge is improved with early therapeutic administration of a new Captisol-Enabled formulation of IV amiodarone (Nexterone-PM101) compared to placebo.
NCT01401647 ↗	Amiodarone, Lidocaine or Neither for Out-Of-Hospital Cardiac Arrest Due to Ventricular Fibrillation or Tachycardia	Completed	U.S. Army Medical Research and Development Command	Phase 3	2012-05-01	The primary objective of the trial is to determine if survival to hospital discharge is improved with early therapeutic administration of a new Captisol-Enabled formulation of IV amiodarone (Nexterone-PM101) compared to placebo.
NCT01401647 ↗	Amiodarone, Lidocaine or Neither for Out-Of-Hospital Cardiac Arrest Due to Ventricular Fibrillation or Tachycardia	Completed	U.S. Army Medical Research and Materiel Command	Phase 3	2012-05-01	The primary objective of the trial is to determine if survival to hospital discharge is improved with early therapeutic administration of a new Captisol-Enabled formulation of IV amiodarone (Nexterone-PM101) compared to placebo.
>Trial ID	>Title	>Status	>Sponsor	>Phase	>Start Date	>Summary

Clinical Trial Conditions for nexterone

Condition Name

Chart
Table

Condition Name for nexterone
Intervention	Trials
Atrial Fibrillation	2
Cardiac Arrest	1
Esophageal Carcinoma	1
Hepatitis C	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Condition MeSH

Chart
Table

Condition MeSH for nexterone
Intervention	Trials
Atrial Fibrillation	2
Hepatitis C	1
Ventricular Fibrillation	1
Tachycardia, Ventricular	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Locations for nexterone

Trials by Country

Map
Table

Trials by Country for nexterone
Location	Trials
United States	9
Canada	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Trials by US State

Map
Table

Trials by US State for nexterone
Location	Trials
Oregon	2
New York	1
Wisconsin	1
Washington	1
Texas	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Progress for nexterone

Clinical Trial Phase

Chart
Table

Clinical Trial Phase for nexterone
Clinical Trial Phase	Trials
Phase 4	2
Phase 3	1
Phase 2	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Status

Chart
Table

Clinical Trial Status for nexterone
Clinical Trial Phase	Trials
Completed	2
Not yet recruiting	2
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Sponsors for nexterone

Sponsor Name

Chart
Table

Sponsor Name for nexterone
Sponsor	Trials
Defence Research and Development Canada	1
Heart and Stroke Foundation of Canada	1
National Heart, Lung, and Blood Institute (NHLBI)	1
[disabled in preview]	4
This preview shows a limited data set Subscribe for full access, or try a Trial

Sponsor Type

Chart
Table

Sponsor Type for nexterone
Sponsor	Trials
Other	7
NIH	2
U.S. Fed	2
[disabled in preview]	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.